GBL - GBL STOCK NEWS

Gabelli Funds will host the 4th Annual Healthcare Symposium with Columbia Business School on November 18, 2022, at the Paley Center in New York City. This half-day event will feature top healthcare executives and physicians discussing vital industry trends. Key topics include advances in diabetes care, the changing site of care, and the evolution of wearables and remote patient monitoring. The symposium's agenda includes several panels with industry experts.

For registration, visit: Event Link.

The GDL Fund (NYSE:GDL) has declared a cash distribution of $0.12 per share, set to be paid on December 16, 2022, to shareholders of record by December 9, 2022. The Board of Trustees is actively monitoring the distribution levels based on the Fund’s net asset value and the financial market conditions. Distributions may include a return of capital, impacting shareholders' cost basis. The GDL Fund aims for absolute returns with total net assets of $201 million and is managed by Gabelli Funds, LLC.

Gabelli Funds will host a session at the IMPACT® Conference in Denver, CO, on November 2, aimed at providing insights into equity investment and market outlook. Key speakers include Mario J. Gabelli and Christopher J. Marangi, who will discuss wealth preservation, growth, and emerging investment opportunities. The conference runs from November 1 to 3 at the Colorado Convention Center. As of September 30, 2022, GAMCO Investors, Inc. managed approximately $27.6 billion in assets.

Gabelli Funds will host the 4th Annual Healthcare Symposium with Columbia Business School on November 18, 2022, at the Paley Center, NYC. This half-day event gathers healthcare leaders to discuss industry trends such as advances in diabetes care, moving care closer to patients, and wearables and remote monitoring. The agenda includes panels led by industry experts including Jeff Jonas and Carri Chan. Registration is available through Eventbrite. Gabelli Funds is a subsidiary of GAMCO Investors, symbol GBL.

GAMCO Investors, Inc. (NYSE: GBL) has announced its expected diluted earnings for Q3 2022, projected between $0.33 and $0.38 per share, down from $1.09 for Q3 2021. As of September 30, 2022, GAMCO's assets under management stood at $27.6 billion, a decrease from $28.7 billion as of June 30, 2022. Further financial details will be disclosed in early November.

GAMCO Investors (NYSE: GBL) announced it has $117 million in cash and cash equivalents, maintaining a debt-free status following the $33.7 million payment on subordinated notes due June 15, 2023. The company, known for its research-driven equity investing, manages a diverse range of investment products through its subsidiaries, including GAMCO Asset Management and Gabelli Funds. GAMCO's comprehensive investment solutions span various sectors, appealing to a broad client base.

GAMCO Investors (NYSE: GBL) has notified the NYSE of its plan to voluntarily delist its Class A common stock and deregister under the Exchange Act. The last trading day on NYSE is expected to be around October 6, 2022. Following this, GAMCO aims to list on the OTCQX platform to maintain liquidity for shareholders. The Board believes that the delisting will reduce operational costs and allow for better resource allocation to business opportunities. Despite these changes, there is uncertainty regarding ongoing market support for its common stock on the OTCQX.